Healthcare Sector Review: Winning and Losing Stocks on Nov 8th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • RadNet Inc. (NASDAQ:RDNT): The shares closed at $2.75, up $0.35, or 14.58%, on the day. Its market capitalization is $102.92 million. About the company: Radnet, Inc. owns and operates outpatient diagnostic imaging centers. The Company’s centers are located throughout California. Get the most recent company news and stock data here >>
  • Hologic, Inc. (NASDAQ:HOLX): The shares closed at $17.84, up $1.61, or 9.92%, on the day. Its market capitalization is $4.68 billion. About the company: Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis. Get the most recent company news and stock data here >>
  • Gentiva Health Services (NASDAQ:GTIV): The shares closed at $4.55, up $0.37, or 8.85%, on the day. Its market capitalization is $139.27 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases. Get the most recent company news and stock data here >>
  • Dendreon Corporation (NASDAQ:DNDN): The shares closed at $7.28, up $0.59, or 8.82%, on the day. Its market capitalization is $1.08 billion. About the company: Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body’s key defense against cancer. Get the most recent company news and stock data here >>
  • Progenics Pharmaceuticals (NASDAQ:PGNX): The shares closed at $7.02, up $0.53, or 8.17%, on the day. Its market capitalization is $236.63 million. About the company: Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics’ principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology. Get the most recent company news and stock data here >>

Losers (% price change)

  • Targacept , Inc. (NASDAQ:TRGT): The shares closed at $7.61, down $11.51, or 60.2%, on the day. Its market capitalization is $254.01 million. About the company: Targacept Inc. is a a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors. Get the most recent company news and stock data here >>
  • Amylin Pharmaceuticals (NASDAQ:AMLN): The shares closed at $9.73, down $1.2, or 10.98%, on the day. Its market capitalization is $1.42 billion. About the company: Amylin Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for diabetes and obesity. The Company’s marketed products include treatments for adults with type 1 and type 2 diabetes. Get the most recent company news and stock data here >>
  • BioScrip Inc. (NASDAQ:BIOS): The shares closed at $5.79, down $0.65, or 10.09%, on the day. Its market capitalization is $316.76 million. About the company: BioScrip, Inc. is a pharmacy benefit management and specialty pharmaceutical organization that partners with managed care organizations and healthcare providers to control prescription drug costs. The Company provides pharmacy benefit products and services and mail order pharmacy services, and is the fulfillment center for online retailers offering prescription and OTC products. Get the most recent company news and stock data here >>
  • ISIS Pharmaceuticals, Inc (NASDAQ:ISIS): The shares closed at $7.53, down $0.75, or 9.06%, on the day. Its market capitalization is $750.45 million. About the company: Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn’s disease, psoriasis, asthma, and cancer. Isis’ broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet